Brief
Scientists warn that Theranos‑style transparency failures are worsening in biotech startups
Researchers cite the Theranos collapse as a warning as private firms increasingly drive scientific discovery.
By Felo News Desk · Published
In a new documentary titled You Can See Everything, filmmaker Nathan Fielder follows Elizabeth Holmes as she prepares for a prison sentence in May 2023, while scientists warn that the transparency problems that led to Theranos’s downfall have intensified in today’s biotech start‑ups.
What happened
Theranos, once a high‑profile Silicon Valley health‑tech company, claimed its device could run hundreds of clinical tests from a single drop of blood. After years of fundraising and partnerships with pharmacies, journalists and scientists exposed in 2015 that the technology lacked any scientific validation. Holmes was convicted of fraud in 2023 and is serving a prison term.
What the reports add
Scientific American notes that John Ioannidis, a Stanford medical school professor who first questioned Theranos in 2015, now believes the same transparency and evidence gaps are “worse today.” Ian Papautsky, a microfluidics researcher at the University of Illinois Chicago, adds that the rise of private‑sector‑driven discovery makes it easier for companies to hide mismanagement, saying, “Many of the start‑ups are not transparent in their technology development.”
What was said
Ioannidis told Scientific American, “I feel kind of uneasy about this being presented as a sensationalist, movie‑quality story about a single bad apple because I see very similar phenotypes to Theranos.” He also warned that “the recipe of her success has been even more widely adopted.” Papautsky said, “On the one hand, you would argue that they have to be, because they’re trying to compete with everyone else. But that also makes it a lot easier to hide the mismanagement and all these other various issues.”
How it came about
The Theranos saga began with ambitious fundraising and high‑profile endorsements before journalists and scientists publicly challenged its claims in 2015. The documentary revisits that period and links the historic case to current concerns about private funding eclipsing publicly funded research, a trend highlighted by the scientists interviewed.
Key facts
- Theranos claimed its device could run hundreds of tests from a single drop of blood. (scientificamerican.com)
- Elizabeth Holmes was convicted of fraud in 2023 and began a prison sentence in May 2023. (scientificamerican.com)
- John Ioannidis says transparency problems in biotech startups are worse today than in 2015. (scientificamerican.com)
- Ian Papautsky warns that private‑sector‑driven discovery can conceal mismanagement. (scientificamerican.com)
Sources
- [1] scientificamerican.com — originally reported as “A decade after Theranos imploded, here’s what scientists want you to know”
